Corrigendum: Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells

Zhenyu Wei,Jiayu Xu,Chengkui Zhao,Min Zhang,Nan Xu,Liqing Kang,Xiaoyan Lou,Lei Yu,Weixing Feng

DOI: https://doi.org/10.3389/fimmu.2024.1379325

IF: 7.3

2024-02-08

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1273507.].

immunology

What problem does this paper attempt to address?

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Ru Zhou,Mahboubeh Yazdanifar,Lopamudra Das Roy,Lynsey M. Whilding,Artemis Gavrill,John Maher,Pinku Mukherjee

DOI: https://doi.org/10.3389/fimmu.2020.628776

IF: 7.3

2020-12-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.01149.].

immunology
Corrigendum: Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL

Yuan Meng,Biping Deng,Luan Rong,Chuo Li,Weiliang Song,Zhuojun Ling,Jinlong Xu,Jiajia Duan,Zelin Wang,Alex H. Chang,Xiaoming Feng,Xiujuan Xiong,Xiaoli Chen,Jing Pan

DOI: https://doi.org/10.3389/fonc.2021.778039

IF: 4.7

2021-10-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.640166.].

oncology
Corrigendum: Immune Tolerance Induced by Hematopoietic Stem Cell Infusion after HLA Identical Sibling Kidney Transplantation

Hongfeng Huang,Qixia Shen,Jingyi Zhou,Xiuyan Yang,Qiuqin Cai,Jia Shen,Shi Feng,Wenqing Xie,Hong Jiang,Jianghua Chen

DOI: https://doi.org/10.3389/fimmu.2022.1052676

IF: 7.3

2022-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.995243.].
Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Pingping Ren,Luying Lu,Shasha Cai,Jianghua Chen,Weiqiang Lin,Fei Han

DOI: https://doi.org/10.3389/fimmu.2024.1513491

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.713540.].
Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Xinyao Hu,Hua Zhu,Shi Feng,Chaoqun Wang,Yingze Ye,Xiaoxing Xiong

DOI: https://doi.org/10.3389/fgene.2022.1117731

IF: 3.7

2023-01-16

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1006357.].

genetics & heredity
Corrigendum: Interpreting flow cytometry with caution: a case report of follicular lymphoma in leukemic phase misdiagnosed as chronic lymphocytic leukemia

Yuan Ren,Congwei Jia,Miao Chen,Wei Wang,Wei Zhang

DOI: https://doi.org/10.3389/fonc.2023.1229649

IF: 4.7

2023-06-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1170598.].

oncology
Author Correction: CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia

Guozhu Xie,Nikola A. Ivica,Bin Jia,Yingzhong Li,Han Dong,Yong Liang,Douglas Brown,Rizwan Romee,Jianzhu Chen

DOI: https://doi.org/10.1038/s41551-020-00677-7

IF: 28.1

2020-12-16

Nature Biomedical Engineering

Abstract:A Correction to this paper has been published: https://doi.org/10.1038/s41551-020-00677-7

engineering, biomedical
Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Meng-Xia Zhang,Li Wang,Lei Zeng,Zi-Wei Tu

DOI: https://doi.org/10.3389/fonc.2021.670714

IF: 4.7

2021-03-18

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.605777.].

oncology
Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”

Bi-Cheng Wang,Bo-Ya Xiao,Peng-Cheng Li,Bo-Hua Kuang,Wang-Bing Chen,Pin-Dong Li,Guo-He Lin,Quentin Liu

DOI: https://doi.org/10.1155/2021/3735726

IF: 4.501

2021-02-25

Journal of Oncology

Abstract:[This corrects the article DOI: 10.1155/2020/2368164.].

oncology
Corrigendum: Circulating cell-free DNA and IL-10 from cerebrospinal fluids aid primary vitreoretinal lymphoma diagnosis

Zhe Zhuang,Yan Zhang,Xiao Zhang,Meifen Zhang,Dongmei Zou,Li Zhang,Congwei Jia,Wei Zhang

DOI: https://doi.org/10.3389/fonc.2022.1104236

IF: 4.7

2023-01-27

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.955080.].

oncology
Corrigendum to “Transferrin-Guided Intelligent Nanovesicles Augment the Targetability and Potency of Clinical PLK1 Inhibitor to Acute Myeloid Leukemia” [bioact. Mater. 21 (march 2023) 499–510]

Yifeng Xia,Jingnan An,Jiaying Li,Wenxing Gu,Yifan Zhang,Songsong Zhao,Cenzhu Zhao,Yang Xu,Bin Li,Zhiyuan Zhong,Fenghua Meng

DOI: https://doi.org/10.1016/j.bioactmat.2023.08.011

IF: 18.9

2024-01-01

Bioactive Materials

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.08.032.].
Erratum: Evaluation of the clinicopathologic features of diffuse large B cell lymphoma after CD19-targeted CAR T-cell therapy emphasizing the potential diagnostic pitfalls.

Jun Zhou,Wenjing Zhang,Yanping Zhang,Saifang Zheng,Luting Zhou,Xiaoqun Yang,Chaofu Wang

2022-01-01

American journal of translational research

Abstract:[This corrects the article on p. 6751 in vol. 12, PMID: 33194070.].
Corrigendum: Prediction of EGFR Mutation Status Based on 18F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma

Guotao Yin,Ziyang Wang,Yingchao Song,Xiaofeng Li,Yiwen Chen,Lei Zhu,Qian Su,Dong Dai,Wengui Xu

DOI: https://doi.org/10.3389/fonc.2021.747316

IF: 4.7

2021-09-07

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.709137.].

oncology
Correction Notice: Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

DOI: https://doi.org/10.1097/HS9.0000000000000987

2023-10-31

HemaSphere

Abstract:[This corrects the article DOI: 10.1097/HS9.0000000000000907.].
Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Si Liu,Honglan Zhou,Gang Wang,Xin Lian

DOI: https://doi.org/10.3389/fcell.2023.1216783

IF: 5.5

2023-06-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.709490.].

cell biology,developmental biology
Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

Wei Zhang,Weiwei Wang,Junlu Wu,Jiale Tian,Wenhui Yan,Yi Yuan,Yiwen Yao,Anquan Shang,Wenqiang Quan

DOI: https://doi.org/10.3389/fonc.2022.1118042

2022-12-15

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.942964.].
Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Yicong Yao,Yi Wang,Denglong Wu,Baoying Hu

DOI: https://doi.org/10.3389/fonc.2021.731942

IF: 4.7

2021-07-21

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.666418.].

oncology
Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Fangling Cheng,Po Zhang,Qungen Xiao,Youwei Li,Minhai Dong,Heping Wang,Dong Kuang,Yue He,Qiuhong Duan,Feng Mao,Baofeng Wang,Dongsheng Guo

DOI: https://doi.org/10.3389/fonc.2020.591112

2020-09-25

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00447.].
Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring

Águeda Molinos-Quintana,Anna Alonso-Saladrigues,Blanca Herrero,Teresa Caballero-Velázquez,Víctor Galán-Gómez,Melissa Panesso,Montserrat Torrebadell,Javier Delgado-Serrano,Concepción Pérez de Soto,Anna Faura,Berta González-Martínez,Ana Castillo-Robleda,Cristina Diaz-de-Heredia,Antonio Pérez-Martínez,José María Pérez-Hurtado,Susana Rives,José Antonio Pérez-Simón

DOI: https://doi.org/10.3389/fimmu.2024.1373852

IF: 7.3

2024-02-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1280580.].

immunology
Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer

Fang-Ze Wei,Shi-Wen Mei,Zhi-Jie Wang,Jia-Nan Chen,Hai-Yu Shen,Fu-Qiang Zhao,Juan Li,Zheng Liu,Qian Liu

DOI: https://doi.org/10.3389/fonc.2020.634122

IF: 4.7

2020-12-18

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.573295.].

oncology

Corrigendum: Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Corrigendum: Short-Interval Sequential CAR-T Cell Infusion May Enhance Prior CAR-T Cell Expansion to Augment Anti-Lymphoma Response in B-NHL

Corrigendum: Immune Tolerance Induced by Hematopoietic Stem Cell Infusion after HLA Identical Sibling Kidney Transplantation

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Corrigendum: Interpreting flow cytometry with caution: a case report of follicular lymphoma in leukemic phase misdiagnosed as chronic lymphocytic leukemia

Author Correction: CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia

Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Corrigendum to “Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis”

Corrigendum: Circulating cell-free DNA and IL-10 from cerebrospinal fluids aid primary vitreoretinal lymphoma diagnosis

Corrigendum to “Transferrin-Guided Intelligent Nanovesicles Augment the Targetability and Potency of Clinical PLK1 Inhibitor to Acute Myeloid Leukemia” [bioact. Mater. 21 (march 2023) 499–510]

Erratum: Evaluation of the clinicopathologic features of diffuse large B cell lymphoma after CD19-targeted CAR T-cell therapy emphasizing the potential diagnostic pitfalls.

Corrigendum: Prediction of EGFR Mutation Status Based on 18F-FDG PET/CT Imaging Using Deep Learning-Based Model in Lung Adenocarcinoma

Correction Notice: Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring

Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer